ERBB2 and cancer: We present the first single-molecule light microscopy observations of the effect on live human cancer cells of anti-cancer immunotherapy drugs cetuximab [25] and trastuzumab [26] which specifically and separately inhibit EGFR activation by targeting either EGFR or HER2, respectively.